眼状態を処置するためのＶＥＧＦ中和プロドラッグ - Ascendis Pharma Off Salmology Division A/S

Title:

眼状態を処置するためのＶＥＧＦ中和プロドラッグ

Document Type and Number:

Japanese Patent JP2015533132

Kind Code:

A

Abstract:

本発明は、1つ以上の眼状態を処置する方法において使用するための、1種以上の薬学的に許容される賦形剤及びVEGF中和プロドラッグを含む医薬組成物であって、このプロドラッグが、VEGF中和生物活性部分を含む、医薬組成物に関する。【選択図】なし

Inventors:

Lau, Halalto
Knappe, Thomas
Laufer, Burghart
Ryman, Romy
Weissblot, Zamuel
Sproue, kennet
Bissec, Nicola
Stark, Sebastian
Voigt, Tobias

Application Number:

JP2015536101A

Publication Date:

November 19, 2015

Filing Date:

October 08, 2013

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Ascendis Pharma Off Salmology Division A/S

International Classes:

A61K39/395; A61K45/00; A61K47/16; A61K47/48; A61P3/10; A61P9/00; A61P9/10; A61P27/02; A61P43/00

Domestic Patent References:

JP2011510954A

2011-04-07

Foreign References:

WO2011123591A1	2011-10-06
WO2011012715A1	2011-02-03
US20050074497A1	2005-04-07

Other References:

PAN, CAROLYN K. ET AL.: "Comparison of Long-Acting Bevacizumab Formulations in the Treatment of Choroidal Neovascularization", JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, vol. 27, no. 3, JPN6017022682, 2011, pages 219 - 224, XP055604172, ISSN: 0004020748, DOI: 10.1089/jop.2010.0158
SCHMUCKER, CHRISTINE ET AL.: "A Safety Review and Meta-Analyses of Bevacizumab and Ranibizumab: Off-Label versus Goldstandard", PLOS ONE, vol. 7, no. 8, JPN7017001994, August 2012 (2012-08-01), pages 42701 - 1, ISSN: 0003946430
BIOMACROMOLECULES, vol. 13, JPN6018050728, 2012, pages 40 - 48, ISSN: 0004020750

Attorney, Agent or Firm:

Yusuke Hiraki
Satoshi Fujita
Eiichi Arai
Natsuo Tanaka
Naoko Kikuta
Hidetoshi Hanai

Previous Patent: JP2015533131

Next Patent: 錠剤製造における水分調節崩壊剤の使用